DGCI
- Health
DCGI orders withdrawal of cancer drug Olaparib for certain treatments
New Delhi: The Drug Controller General of India has asked drug regulators in all states and Union territories to withdraw AstraZeneca’s anti-cancer drug Olaparib tablets for treatment in patients who have received…
- India
Fake medicines: After WHO alerts, DGCI asks states to hold strict vigil
New Delhi: The Drugs Controller General of India (DCGI) has directed the drugs controllers of all states and Union territories to keep a strict vigil on the sale and distribution of falsified…
- India
Abbott recalls antacid Digene gel, DGCI issues alert
Leading American multinational medical devices and health care company, Abbott voluntarily recalled its antacid Digene gel after the Drugs Control General of India (DCGI) received a complaint on 9 August, alleging bitter…
- World
Dont use propylene glycol supplied by Delhi firm, orders DGCI post cough syrup deaths
New Delhi: India’s drug regulator has directed drug manufacturers not to use propylene glycol supplied by a Delhi-based company which provided the ingredient to Marion Biotech, whose cough syrups were alleged to…
- Business
Amazon, Flipkart among 20 e-tailors given notices for selling drugs without licence
Delhi: Amazon and Flipkart Health plus are among the 20 online sellers that have been issued show-cause notices by the Drugs Controller General of India (DCGI) over the online sale of drugs…
- India
Bharat Biotech’s intranasal COVID vaccine approved by govt, to be available on CO-WIN
New Delhi: Bharat Biotech’s intranasal Covid vaccine has been approved by the Union Health Ministry for inclusion in the vaccination programme as a booster dose for those above 18 years of age,…
- Kolkata
Haryana sends samples to lab after WHO alert on cough syrups made by Sonipat firm
Chandigarh: Samples of four cough syrups manufactured by a Sonipat-based firm have been sent to the Central Drugs Laboratory in Kolkata for examination, Haryana’s Health Minister Anil Vij said Thursday, a day…
- Hyderabad
Hyderabad based Corbevax gets DGCI nod as COVID-19 booster for 18+
New Delhi: Hyderabad-based Pharmaceuticals firm Biological E Ltd (BE) on Saturday announced that its Covid-19 vaccine Corbevax has been cleared by the Drugs Controller General of India (DCGI) as a heterologous Covid-19…
